LP Area »
  • Home
  • About Us
  • Our Team
  • Portfolio Companies
  • News
  • Contact Us

Venture Investors


SubscribeIn the News

NOVELOS THERAPEUTICS PRICES $5.9M PUBLIC OFFERING

Thursday, December 1st, 2011 | Healthcare

CHROMATIN: AREA RANCHERS GROW FEEDSTOCK FOR BIOFUEL

Wednesday, November 30th, 2011 | Clean Tech

INVIRAGEN INITIATES A PHASE 2 CLINICAL STUDY OF DENVAX, A RECOMBINANT, TETRAVALENT DENGUE VACCINE

Monday, November 28th, 2011 | Healthcare

NEUWAVE TO START SELLING CANCER TREATMENT DEVICE

Tuesday, November 22nd, 2011 | Healthcare

AKEBIA INITIATES PHASE 1 STUDY OF FIRST-IN-CLASS HPTPβ INHIBITOR FOR DIABETIC MACULAR EDEMA

Monday, November 21st, 2011 | Healthcare

AKEBIA THERAPEUTICS ANNOUNCES PRESENTATION OF CLINICAL DATA AT KIDNEY WEEK 2011

Tuesday, November 15th, 2011 | Healthcare

EUTHYMICS BIOSCIENCE, INC. APPOINTS DR. RANDALL MARSHALL, LEADER IN THE PSYCHIATRIC FIELD, AS EXECUTIVE DIRECTOR, MEDICAL AFFAIRS

Wednesday, November 9th, 2011 | Healthcare
« Previous Entries Next Entries »

Categories

  • Venture Investors
  • Healthcare
  • Technology
  • Clean Tech

Archive

  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006

Search

 
©2012 Venture Investors LLC, All Rights Reserved
  • Home
  • About Us
  • Our Team
  • Portfolio Companies
  • News
  • Contact Us